Market Snapshot

BSE Sensex: 85650.66 0.45%
BSE 500: 37374.89 0.33%
BSE 200: 11798.67 0.44%
BSE 100: 27376.44 0.50%
BSE MidCap: 46607.71 0.18%
BSE SmallCap: 51102.45 -0.65%
BSE BANKEX: 66932.52 0.73%
BSE IT: 37382.27 0.69%
Nifty 50: 26165.1 0.50%
Nifty 500: 23817.2 0.32%
Nifty 200: 14530.3 0.44%
Nifty 100: 26676.5 0.45%
Nifty Midcap 100: 60543.9 0.40%
Nifty Small 100: 17514.7 -0.53%
Nifty IT: 38672.85 0.81%
Nifty PSU Bank: 8372.65 1.40%

News:

Tenneco Clean Air India Q2 PAT...
Wipro Ltd rises for third cons...
Infosys Ltd spurts 1.75%, rise...
HCL Technologies Ltd gains for...
National Aluminium Company Ltd...

Panacea Biotec Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

05 Dec 2025 | 02:13 PM

346.60

1.85 (0.54%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-22.58%

Return (1Y)

Underperformed BSE Healthcare by 22.69%
More Volatile

3.28%

Standard Deviation (1Y)

Higher than BSE Healthcare by 2.32%
Not so consistent

4/12

Months

underperformed BSE Healthcare
AxisDirect View

No View

52 Week High-Low

581

282

News & Announcements

Panacea Biotec reports consolidated net loss of Rs 13.92 crore in the September 2025 quarter
20 days ago

Panacea Biotec reports consolidated net loss of Rs 13.92 crore in the September 2025 quarter

15 - Nov - 2025 12:00 | 20 days ago

Net loss of Panacea Biotec reported to Rs 13.92 crore in the quarter ended September 2025 as against net profit of Rs 4.80 crore during the previous quarter ended September 2024. Sales declined 4.22% to Rs 141.13 crore in the quarter ended September 2025 as against Rs 147.35 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 141.13 147.35 -4

OPM % -12.61 4.75 -

PBDT -13.53 10.67 PL

PBT -21.87 1.99 PL

NP -13.92 4.80 PL

Powered by Capital Market - Live News
Panacea Biotech bags vaccine supply deal from PAHO
23 days ago

Panacea Biotech bags vaccine supply deal from PAHO

12 - Nov - 2025 12:00 | 23 days ago

Easyfive TT provides active immunization against severe diseases namely Diphtheria, Haemophilus influenzae type b, Hepatitis-B, Pertussis, and Tetanus.
The company will supply Easyfive TT vaccine during calendar year 2026 and 2027.
Panacea Biotec is a research-based biotechnology companies engaged in the business of research, development, manufacture and marketing of vaccines in India and international markets.
The company reported consolidated net profit of Rs 4.05 crore in Q1 FY26 as against net loss of Rs 15.80 crore in Q1 FY25. Revenue from operations jumped 44.1% year on year to Rs 166.70 crore in Q1 FY26.
The counter declined 2.24% to end at Rs 396.40 on Tuesday, 11 November 2025.
Powered by Capital Market - Live News
Panacea Biotec to discuss results
30 days ago

Panacea Biotec to discuss results

05 - Nov - 2025 12:00 | 30 days ago

Panacea Biotec will hold a meeting of the Board of Directors of the Company on 14 November 2025.
Powered by Capital Market - Live News
Panacea Biotec secures order of Rs 127 cr from CMSS, Govt. of India
57 days ago

Panacea Biotec secures order of Rs 127 cr from CMSS, Govt. of India

09 - Oct - 2025 12:00 | 57 days ago

Panacea Biotec that the Central Medical Services Society, Ministry of Health and Family Welfare, Government of India (CMSS) has, vide its Letter of Acceptance (LOA) dated 08 October 2025, accepted the Company's offer for supply of bivalent oral polio vaccine (bOPV) against the tender issued by it in this regard. As per the LOA, the Company will supply the vaccine worth Rs.127.20 crore in several tranches over a period of 90 - 480 days from the date of issuance of LOA.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

FII shareholding in Panacea Biotec Ltd has increased by 34.81% since past 3 Months
FII shareholding in Panacea Biotec Ltd has increased by 187.11% since past 1 Year
Panacea Biotec Ltd has the Lowesr P/E ratio according to FY 202503 data among stocks in Pharmaceuticals Sector
Panacea Biotec Ltd has the Lowesr P/B ratio according to FY 202503 data among stocks in Pharmaceuticals Sector

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	141.13	147.35	-4
OPM %	-12.61	4.75	-
PBDT	-13.53	10.67	PL
PBT	-21.87	1.99	PL
NP	-13.92	4.80	PL

General Notifications

My Notifications

Research Notifications

Panacea Biotec Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

346.60 1.85 (0.54%)

News & Announcements

Price vs Volume

Stock Trivia

Panacea Biotec Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

346.60

1.85 (0.54%)